Atorvastatin-Calcium-Trihydrate shortage — AU supply status & alternatives

Atorvastatin-Calcium-Trihydrate

ATC C10AA05

In shortage · Australia

Ezetast

In declared shortage · 🇦🇺 Australia

Critical shortage

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Oct 2026

Sponsor est. via TGA

Product attributes reference data we hold

Active ingredient (INN)	Atorvastatin-Calcium-Trihydrate
Brand names	Ezetast
ATC level 5	C10AA05
ATC level 4	C10AA

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Verified timeline regulator events

🇦🇺 10 July 2026

low reported

🇦🇺 25 June 2026

high reported

🇦🇺 22 June 2026

high reported

🇦🇺 17 June 2026

Shortage resolved

🇦🇺 8 May 2026

Shortage resolved

🇦🇺 31 Mar 2026

Shortage resolved

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.